Pharmacovigilance of patients with multiple myeloma being treated with bortezomib and/or thalidomide
Braz. j. med. biol. res; 49 (6), 2016
In order to evaluate the main adverse effects of drug protocols using bortezomib and/or thalidomide for the treatment of multiple myeloma, we conducted a prospective study. Data were collected through interviews, clinical observation, and from hospital records. A total of 59 patients were included. There...
Antineoplásicos/efectos adversos, Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos, Bortezomib/efectos adversos, Diarrea/inducido químicamente, Inmunosupresores/efectos adversos, Mieloma Múltiple/tratamiento farmacológico, Neutropenia/inducido químicamente, Enfermedades del Sistema Nervioso Periférico/inducido químicamente, Farmacovigilancia, Estudios Prospectivos, Factores de Riesgo, Talidomida/efectos adversos, Resultado del Tratamiento